Research Program

Cancer Genomics and Precision Oncology

Cancer genomics is a rapidly evolving field that involves the comprehensive study of the complexities of cancerous cells at the genetic level. Using advanced tools and technologies such as next-generation sequencing (NGS), scientists can analyze the entire genome of cancer cells, enabling them to understand the genetic mutations and abnormalities that contribute to cancer development and progression. Cancer genomics and precision oncology are interrelated to identify genetic mutations, to develop targeted therapies, to make personalized treatment plans, to assess and prevent risk, to predict progonosis, and to try clinical trials.